Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Webinar

Building Trust in Data – Transparency, Traceability, and the Human Element

March 26, 2026 – APAC 10:00-10:45am IST, EMEA 9:00-9:45am GMT, Americas 2:00-2:45pm ET
Webinar

Explore Smarter, Faster PK/PD with Phoenix

April 7, 2026 – 10-11 AM ET/CET/JST
Webinar

Leveraging the full potential of PBPK models to accelerate drug development

April 9, 2026

Latest late clinical blogs

Meet our experts at the following events

Live Events

Certara IQ™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our experts are bringing hands-on, indepth
Conference

Quantitative Systems Pharmacology Conference

April 8 - 10, 2026
Live Events

Certara IQ™ Workshop

April 16, 2026

All late clinical resources

Pharmacometrics Under Pressure

Certara Products - Phoenix, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

What are Common Bioequivalence Study Mistakes?

Certara Products - Phoenix, Certara Products - Simcyp, Blog

Rethinking Trial Design With Bayesian Approaches

Certara Services, Press Coverage, Video

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Pharmacometrics, Blog

FDA Support Drives Shift Toward Bayesian Trial Design

Certara Services, Press Coverage, Video

Single Pivotal Trials Demand Stronger Data and Risk Strategies

Certara Services, Press Coverage

Discovery & Development Europe 2026

Certara Products, Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Advancing Bayesian Methods in Clinical Trials

Certara Services, Press Coverage, Video

Building Trust in Data – Transparency, Traceability, and the Human Element

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Webinar

Understanding and Calculating Steady State Pharmacokinetics

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog, Knowledge Base

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.